检索结果-南通市图书馆

CACA guidelines for holistic integrative management of glioma

在线全文

学校读者我要写书评

暂无评论

Holistic Integrative Oncology 2022年第1期1卷 292-317页

作者： Daiming Fan Tao Jiang Wenbin Ma Chuanlu Jiang Yongping You Ying Mao Xiaoguang Qiu Chunsheng Kang gang Li qing Mao Xuejun Yang Zhiyong qin Zhixiong Liu Weimin Wang Xinting Wei Wenbin Li {3.nhui Liu Rutong {3. Xinguang {3. Dezhi Kang Yonggao Mou Lei Wang Wei Zhang zhaoshi Bao Ruichao Chai Baoshi chen Xing Fan Sheng{3. Fang Guanzhang Li Lianwang Li Shouwei Li Xing Liu Yanwei Liu Xia Shan Liang Wang Yinyan Wang {3. Wang Zheng Wang Zhiliang Wang chenxing Wu Wei Yan Pei Yang Gan You Chuanbao Zhang Zhong Zhang Zheng zhao Department of Neurosurgery Beijing Tiantan HospitalCapital Medical UniversityNo.119 South 4th Ring West RoadFengtai DistrictBeijing 100070China

Glioma of the brain is a kind of tumor originating from neuroglial *** is the most common primary intracranial tumor,accounting for~3.%of all central nervous system tumors and 80% of malignant brain *** is characterized by high disability and recurrence *** disease seriously threatens the life of patients,afects their quality of life,and brings a heavy economic and psychological burden to patients,families,and *** the progression of molecular genetic testing technology and the completion of various clinical trials,the classifcation scheme for glioma is increasingly well *** and treatment regimens,including traditional and new regimens,are becoming increasingly specialized and *** purpose is to develop a clinical diagnosis and treatment guideline for glioma in the chinese population suitable for chinese doctors and the general population based on domestic and international glioma research ***,domestic practitioners in the feld can obtain current information and provide better service to patients with glioma,promoting the development of domestic clinical medicine and basic research on glioma.

关键词： Glioma Clinical guideline Holistic integrative medicine

Data release of the LAMOST pilot survey

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2012年第9期12卷 1243-1246页

作者： A-Li Luo Hao-Tong Zhang Yong-Heng zhao gang zhao Xiang-Qun Cui Guo-Ping Li Yao-Quan Chu Jian-Rong Shi gang Wang Jian-Nan Zhang Zhong-Rui Bai Xiao-Yan chen Feng-Fei Wang Yan-Xin Guo Jian-Jun chen Bing Du Xiao Kong Ya-Juan Lei Yin-Bi Li Yi-Han Song yue Wu Yan-Xia Zhang Xin-Lin Zhou Fang Zuo Peng Du Lin He Wen Hou Yi-Qiao Dong Jian Li Guang-Wei Li Shuang Li Jing Song yuan Tian Meng-Xin Wang Yong-Hui Hou Zhi-Ying Huo Hong-Zhuan Hu Ning-Sheng Hu Zhong-Wen Hu Lei Jia Fang-Hua Jiang Xiang Jiang Zi-Bo Jiang Ge Jin Ai-Hua Li Qi Li Yin-Dun Mao Zheng-Hong Tang qing-Sheng Tao Liang-Ping Tu Da-qing Wang Dan Wang Jian-Ping Wang Lei Wang Shou-Guan Wang Shu-qing Wang Ya-Nan Wang You Wang yue-Fei Wang Ming-Zhi Wei Xiang-Xiang Xue Xiao-Zheng Xing Ling-Zhe Xu Xin-Qi Xu Yan Xu De-Hua Yang Shi-Hai Yang Zheng-Qiu Yao Yong yu Hui yuan Chao Zhai En-Peng Zhang Jing Zhang Li-Ping Zhang WeiZhang Yong Zhang Zhen-Chao Zhang Ming zhao Fang Zhou Yong-Tian Zhu Jie Zhu Si-cheng Zou National astronomical observatories Chinese Academy of Sciences Beijing 100012 China lal @ lamost o rg Nanjing Institute of astronomical Optics and Technology National Astronomical ObservatoriesChinese Academy of Sciences Nanjing 210042 China University of Science and Technologyof China Hefei 230026 China Shanghai astronomical Observatory Chinese Academy of Sciences Shanghai 200030 China Institute of Architecture Design and Research Chinese Academy of Sciences Beijing 100190China

This paper describes the data release of the LAMOST pilot survey, which includes data reduction, calibration, spectral analysis, data products and data access. The accuracy of the released data and the information about the FITS headers of spectra are also introduced. The released data set includes 3.9 000 spectra and a catalog of these objects.

关键词： techniques: spectroscopic survey — data reduction — data release

基于气象条件指数的我国重点区域PM_(2.5)和臭氧复合污染气象影响评估

在线全文

学校读者我要写书评

暂无评论

环境科学 2023年第12期44卷 6433-6440页

作者：杨欣杨元琴李红高健牛军捷储王辉刘世杰陈义珍何友江赵妤希中国环境科学研究院北京100012 中国气象科学研究院北京100081 芜湖市生态环境局芜湖241000

气象条件变化对复合污染的发生发展起重要作用,基于PM_(2.5)和O_(3.不同的污染形成机制,利用污染气象长期观测数据,分别采用统计运算和深度学习方法,构建了PM_(2.5)和O_(3.气象条件指数,形成以气象条件指数开展区域大气复合污染气象特... 详细信息

气象条件变化对复合污染的发生发展起重要作用,基于PM_(2.5)和O_(3.不同的污染形成机制,利用污染气象长期观测数据,分别采用统计运算和深度学习方法,构建了PM_(2.5)和O_(3.气象条件指数,形成以气象条件指数开展区域大气复合污染气象特征和影响贡献的研究方法,并对剔除区域气象差异影响的污染分布与变化进行了量化分析.结果表明,2021年夏季我国中东部重点区域污染气象条件整体上呈北差南优(指数:“2+26”城市>苏皖鲁豫交界>长三角地区),6月最差、7月最好的分布特征,当区域内城市PM_(2.5)气象条件指数>3.且O_(3.气象条件指数>100时,“双高”污染开始出现,随O_(3.气象条件指数增大,“双高”频率不断升高;与上年同期相比,各地区ρ(PM_(2.5))受气象条件改善影响分别降低3.9、3.3.1.4μg·m^(-3.,平均占到各地ρ(PM_(2.5))降低的58.5%,O_(3.污染气象条件则呈北转好、南转差变化,在长三角地区带来ρ(O_(3.)近2.8μg·m^(-3.的增长;剔除气象差异影响后的PM_(2.5)高值分布在沿渤海、省际交界及区域南部,O_(3.高值则集中在太行山沿线、泰山周边以及长三角部分地区,利用单个城市剔除气象差异后的逐日浓度变化可实现对临时管控措施执行情况的实时监督和调度.

关键词：气象条件指数大气复合污染双高定量评估气象差异剔除

Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)

在线全文

学校读者我要写书评

暂无评论

Journal of Pancreatology 2021年第2期4卷 49-66页

作者： Yinmo Yang Xueli Bai Dapeng Bian Shouwang Cai Rufu chen Feng Cao Menghua Dai Chihua Fang Deliang Fu Chunlin Ge Xiaochao Guo Chunyi Hao Jihui Hao Heguang Huang Zhixiang Jian gang Jin Fei Li Haimin Li Shengping Li Weiqin Li Yixiong Li Hongzhen Li Tingbo Liang Xubao Liu Wenhui Lou Yi Miao Yiping Mou chenghong Peng Renyi qin chenghao Shao Bei Sun Guang Tan Xiaodong Tian Huaizhi Wang Lei Wang Wei Wang Weilin Wang Junmin Wei Heshui Wu Wenming Wu Zheng Wu Jingyong Xu Changqing Yan Xiaoyu Yin Xianjun yu Chunhui yuan Taiping Zhang Jixin Zhang Jun Zhou yupei zhao on behalf of the chinese Pancreatic Surgery Association Department of General Surgery Peking University First HospitalBeijing Department of Hepatobiliary and Pancreatic Surgery the First Affiliated Hospital of Medical CollegeZhejiang UniversityHangzhouZhejiang Province Departments of Endoscopy Peking University First HospitalBeijing Institute of Hepatobiliary Surgery of PLA Chinese PLA General HospitalBeijing Department of Pancreatobiliary Surgery Sun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhouGuangdong Province Department of General Surgery Xuanwu HospitalCapital Medical UniversityBeijing Department of General Surgery Peking Union Medical College HospitalChinese Academy of Medical Science&Peking Union Medical CollegeBeijing Department of Hepatobiliary Surgery Zhujiang HospitalSouthern Medical UniversityGuangzhouGuangdong Province Department of Pancreatic Surgery Huashan Hospital Fudan UniversityShanghai Department of General Surgery The First Affiliated Hospital of China Medical UniversityShenyangLiaoning Province Department of Imaging Peking University First HospitalBeijing Department of Hepato-Pancreato-Biliary Surgery Peking University Cancer Hospital&InstituteBeijing Department of Pancreatic Cancer Tianjin Medical University Cancer Institute and HospitalTianjin Department of General Surgery Fujian Medical University Union HospitalFuzhouFujian Province Department of General Surgery Guangdong Provincial People’s HospitalGuangzhouGuangdong Province Department of Hepatobiliary Pancreatic Surgery Changhai Hospital Affiliated to Navy Medical UniversityShanghai Department of Hepatobiliary Surgery Xijing HospitalFourth Military Medical UniversityXi’anShaanxi Province Department of Pancreatobiliary Surgery Sun Yat-sen University Cancer CenterGuangzhouGuangdong Province Department of General Surgery Jinling HospitalMedical School of Nanjing UniversityNanjingJiangsu Province Department of General Surgery Xiangya HospitalCentral South UniversityChangshaHunan Province Department of Radiation Oncology Peking University First H

The incidence of pancreatic cancer has been rising worldwide,and its clinical diagnosis and treatment remain a great *** present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years,chinese Pancreatic Association,the chinese Society of Surgery,chinese Medical Association revised the Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China(2014)after reviewing evidence-based and problem-oriented literature published during 2015-2021,mainly focusing on highlight issues regarding diagnosis and surgical treatment of pancreatic cancer,conversion strategies for locally advanced pancreatic cancer,treatment of pancreatic cancer with oligo metastasis,adjuvant and neoadjuvant therapy,standardized processing of surgical specimens and evaluation of surgical margin status,systemic treatment for unresectable pancreatic cancer,genetic testing,as well as postoperative follow up of patients with pancreatic *** recommendation items were finally proposed based on the above issues,and the quality of evidence and strength of recommendations were graded using the Grades of Recommendation,Assessment,Development,and Evaluation *** guideline aims to standardize the clinical diagnosis and therapy,especially surgical treatment of pancreatic cancer in China,and further improve the prognosis of patients with pancreatic cancer.

关键词： Diagnosis Guideline Multidisciplinary team Pancreatic cancer Treatment

Consensus of clinical diagnosis and treatment for non-functional pancreatic neuroendocrine neoplasms with diameter<2 cm

在线全文

学校读者我要写书评

暂无评论

Journal of Pancreatology 2023年第3期6卷 87-95页

作者： Wu Wenming Cai Shouwang chen Rufu Fu Deliang Ge Chunlin Hao Chunyi Hao Jihui Huang Heguang Jian Zhixiang Jin gang Li Fei Li Haimin Li Shengping Li Weiqin LiYixiong Liang Tingbo Liu Xubao Lou Wenhui Miao Yi Mou Yiping Peng chenghong qin Renyi Shao chenghao Sun Bei Tan Guang Wang Huaizhi Wang Lei Wang Wei Wang Weilin Wei Junmin Wu Heshui Wu Zheng Yan Changqing Yang Yinmo Yin Xiaoyu yu Xianjun yuan Chunhui zhao yupei Department of General Surgery State Key Laboratory of Complex Severe and Rare DiseasesPeking Union Medical College HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing 100730China Department of Hepatobiliary Surgery PLA General HospitalBeijing 100853China Department of General Surgery Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou 510080China Department of Pancreatic Surgery Huashan HospitalShanghai Medical CollegeFudan UniversityShanghai 200040China Department of Hepatobiliary and Pancreatic Surgery Hunnan Division of The First Hospital of China Medical UniversityShenyang 110167China Department of Hepato-Pancreato-Biliary Surgery Peking University Cancer Hospital&InstituteBeijing 100142China Department of Pancreatic Cancer Tianjin Medical University Cancer Institute and HospitalTianjin 300060China Department of General Surgery Fujian Medical University Union HospitalFuzhou 350001China Department of General Surgery Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou 510000China Department of Hepatobiliary Pancreatic Surgery Changhai Hospital Affiliated to Navy Medical University(Second Military Medical University)Shanghai 200433China Department of General Surgery Xuanwu HospitalCapital Medical UniversityBeijing 100053China Department of Hepatobiliary Surgery Xijing HospitalFourth Military Medical UniversityXi’an 710032China Department of Hepatobiliary and Pancreatic Surgery Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer MedicineGuangzhou 510060China Department of Critical Care Medicine Jinling HospitalMedical School of Nanjing UniversityNanjing 210002China Department of General Surgery Xiangya HospitalCentral South UniversityChangsha 410008China Department of Hepatobiliary and Pancreatic Surgery the First Affiliated HospitalZhejiang University School of MedicineHangzhou 310003China Department

In clinical practice,pancreatic neuroendocrine neoplasms(pNENs)with a diameter smaller than 2 cm are commonly referred to as small *** to their generally favorable biological characteristics,the diagnosis and treatment of small pNENs differ from other pNENs and are somewhat *** response to this,the chinese Pancreatic Surgery Association,chinese Society of Surgery,chinese Medical Association have developed a consensus on the diagnosis and treatment of small pNENs,which is based on evidence-based medicine and expert *** consensus covers various topics,including concepts,disease assessment,treatment selection,follow-up,and other relevant aspects.

关键词： 2 cm Clinical diagnosis Non-functional pancreatic neuroendocrine neoplasms Treatment

在线全文

学校读者我要写书评

暂无评论

遗传性耳聋基因治疗临床指南

实用医院临床杂志 2024年第2期21卷 39-44页

作者：齐洁玉谈方志张李燕陆玲王洪阳李文妍刘闻闻付小龙贺祖宏丁小琼孙珊方巧军董耀东朱学伟童步升曹现宝郭敏范欣淼汪芹马璐张天虹于亚峰李永新樊建刚崔勇吴佩娜张宏征唐杰郭维维查定军叶放蕾何双八曹卫杨见明钱晓云赵宇孙敬武陈晓巍孙宇夏明王秋菊袁慧军冯永孔维佳杨仕明王海波高下李华伟徐磊柴人杰东南大学数字医学工程全国重点实验室附属中大医院耳鼻咽喉头颈外科生命科学与技术学院生命与健康高等研究院江苏省生物医学高新技术研究重点实验室江苏南京210096 南通大学神经再生联合创新中心江苏南通226001 北京理工大学航天中心医院神经内科生命学院北京10081 南京大学医学院附属鼓楼医院耳鼻喉头颈外科江苏省医学重点学科(实验室)江苏南京210008 中国人民解放军总医院耳鼻咽喉头颈外科医学部北京100853 听觉与平衡觉全国重点实验室北京100853 国家耳鼻咽喉疾病临床医学研究中心北京100853 聋病教育部重点实验室北京100853 聋病防治北京市重点实验室北京100853 复旦大学附属眼耳鼻喉科医院医学神经生物学国家重点实验室教育部脑科学前沿研究中心上海200031 复旦大学生物医学研究所上海200032 国家卫健委听觉医学重点实验室上海200031 复旦大学脑科学研究院和脑科学协同创新中心上海200032 山东大学山东省耳鼻喉医院耳鼻咽喉头颈外科山东济南250022 山东省耳鼻喉研究所山东济南250022 山东第一医科大学/山东省医学科学院医学科技创新中心山东济南250000 武汉大学中南医院耳鼻咽喉头颈外科湖北武汉430071 东南大学附属中大医院耳鼻咽喉头颈外科江苏南京210009 复旦大学附属眼耳鼻喉科医院耳鼻喉科上海200032 安徽医科大学第二附属医院耳鼻咽喉头颈外科安徽合肥230601 中国医科大学附属盛京医院耳鼻咽喉头颈外科辽宁沈阳110004 吉林大学中日联谊医院耳鼻咽喉头颈外科吉林长春130033 安徽医科大学第一附属医院耳鼻咽喉头颈外科安徽合肥230022 云南省第一人民医院耳鼻喉科云南昆明650032 昆明医科大学第一附属医院耳鼻喉科云南昆明650032 中国医学科学院北京协和医学院北京协和医院耳鼻咽喉科北京100730 中南大学湘雅二医院耳鼻咽喉头颈外科湖南长沙410008 南华大学衡阳医学院基础医学院细胞生物学与遗传学教研室细胞应激生物学衡阳市重点实验室湖南衡阳421001 哈尔滨医科大学附属第一医院黑龙江哈尔滨150001 苏州大学附属第一医院耳鼻咽喉科江苏苏州215006 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科北京100730 四川省医学科学院·四川省人民医院/电子科技大学附属医院耳鼻咽喉头颈外科四川成都610072 广东省人民医院耳鼻咽喉头颈外科/广东省医学科学院/南方医科大学广东广州510080 南方医科大学珠江医院耳鼻咽喉头颈外科广东广州510282 空军军医大学西京医院耳鼻咽喉-头颈外科陕西西安710032 郑州大学第一附属医院耳科河南郑州450000 东南大学医学院附属南京同仁医院耳鼻咽喉头颈外科江苏南京211102 四川大学华西医院耳鼻咽喉头颈外科四川成都610041 中国科学技术大学附属第一医院耳鼻咽喉头颈外科安徽合肥230001 华中科技大学同济医学院附属协和医院耳鼻咽喉头颈外科湖北武汉430022 山东第一医科大学附属山东省立医院耳鼻咽喉科山东济南250021 山东省医学科学院医学科技创新中心山东济南250021 山东大学附属山东省立医院耳鼻咽喉科山东济南250021 国家卫生健康委耳鼻咽喉重点实验室山东济南250021 四川大学华西医院罕见病研究院四川成都6010041 南华大学衡阳医学院南华大学附属妇幼保健院湖南长沙410008 中南大学湘雅医院耳鼻咽喉头颈外科湖南长沙410008 上海人工耳蜗工程技术研究中心上海200031 东南大学深圳研究院广东深圳518063

遗传性耳聋是一种常见的遗传性疾病,新生儿的发病率为1‰~3.。患者终身携带致病突变,导致不可逆性耳聋,至今尚无临床可用的治疗药物。在部分遗传性耳聋动物模型中,基因治疗已被证实为潜在有效的治疗方法。国内外已开展了多项遗传性耳... 详细信息

遗传性耳聋是一种常见的遗传性疾病,新生儿的发病率为1‰~3.。患者终身携带致病突变,导致不可逆性耳聋,至今尚无临床可用的治疗药物。在部分遗传性耳聋动物模型中,基因治疗已被证实为潜在有效的治疗方法。国内外已开展了多项遗传性耳聋基因治疗的临床试验。其中,由东南大学附属中大医院牵头,联合国内多家医院成功开展的遗传性耳聋基因治疗临床试验,取得了显著的疗效,并积累了丰富的经验。为规范遗传性耳聋基因治疗并提供临床研究指导,全国多家医院的耳科专家讨论制定了遗传性耳聋基因治疗临床指南,内容涵盖了伦理审查、遗传性耳聋的诊断和入组标准、临床前准备、药物、疗效与安全性评估标准、术后言语康复等。本指南将为耳聋基因治疗的临床诊疗提供规范的理论和技术指导。

关键词：遗传性耳聋基因治疗临床指南

Advances in nuclear detection and readout techniques

在线全文

学校读者我要写书评

暂无评论

Nuclear Science and Techniques 2023年第12期34卷 281-358页

作者： Rui He Xiao‑Yang Niu Yi Wang Hong‑Wei Liang Hong‑Bang Liu Ye Tian Hong‑Lin Zhang Chao‑Jie Zou Zhi‑Yi Liu yun‑Long Zhang Hai‑Bo Yang Ju Huang Hong‑Kai Wang Wei‑Jia Han Bei Cao gang chen Cong Dai Li‑Min Duan Rui‑Rui Fan Fang‑Fa Fu Jian‑Hua Guo Dong Han Wei Jiang Xian‑{3. Li Xin Li Zhuo‑Dai Li yu‑Tie Liang Shun Liao De‑Xu Lin cheng‑Ming Liu Guo‑Rui Liu Jun‑Tao Liu Ze Long Meng‑chen Niu Hao Qiu Hu Ran Xiang‑Ming Sun Bo‑Tan Wang Jia Wang Jin‑Xiang Wang Qi‑Lin Wang Yong‑Sheng Wang Xiao‑Chuan Xia Hao‑{3.g Xie He‑Run Yang Hong Yin Hong yuan Chun‑Hui Zhang Rui‑Guang zhao Ran Zheng cheng‑Xin zhao Institute of Modern Physics Chinese Academy of SciencesLanzhou 730000China School of Nuclear Science and Technology University of Chinese Academy of SciencesBeijing 100049China Advanced Energy Science and Technology Guangdong Laboratory Huizhou 516000China Key Laboratory of Particle and Radiation Imaging Department of Engineering PhysicsTsinghua UniversityBeijing 100084China School of Integrated Circuits Dalian University of TechnologyDalian 116020China Guangxi Key Laboratory for Relativistic Astrophysics School of Physical Science and TechnologyGuangxi UniversityNanning 530004China School of Nuclear Science and Technology Lanzhou UniversityLanzhou 730000China State Key Laboratory of Particle Detection and Electronics University of Science and Technology of ChinaHefei 230026China Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Electronic Engineering School Heilongjiang UniversityHarbin 150080China Spallation Neutron Source Science Center Dongguan 523803China Micro‑electronic Department Harbin Institute of TechnologyHarbin 150001China Purple Mountain Observatory Chinese Academy of SciencesNanjing 210034China Liaoning academy of Materials Shenyang 110167China Istituto Nazionale di Fisica Nucleare Sezione di PerugiaPerugiaItaly School of Mathematics and Physics Chengdu University of TechnologyChengdu 620035China PLAC Key Laboratory of Quark and Lepton Physics(MOE)Central China Normal UniversityWuhan 430079China School of Electronics and Information Northwestern Polytechnical UniversityXi’an 710129China State Key Lab of Superhard Materials College of PhysicsJilin UniversityChangchun 130012China School of Computer Science Northwestern Polytechnical UniversityXi’an 710129China

“A Craftsman Must Sharpen His Tools to Do His Job,”said *** detection and readout techniques are the foundation of particle physics,nuclear physics,and particle astrophysics to reveal the nature of the ***,they are being increasingly used in other disciplines like nuclear power generation,life sciences,environmental sciences,medical sciences,*** article reviews the short history,recent development,and trend of nuclear detection and readout techniques,covering Semiconductor Detector,Gaseous Detector,Scintillation Detector,Cherenkov Detector,Transition Radiation Detector,and Readout *** explaining the principle and using examples,we hope to help the interested reader underst and this research field and bring exciting information to the community.

关键词： Silicon detector Wide bandgap detector Time projection chamber(TPC) Multigap resistive plate chamber detector(MRPC) Scintillation detector Calorimeters Cherenkov detector Transition radiation detector Artificial intelligence Trigger-less readout

Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China(2020)#

在线全文

学校读者我要写书评

暂无评论

International Journal of Dermatology and Venereology 2021年第1期4卷 1-9页

作者： Xu Yao Zhi-Qiang Song Wei Li yun-Sheng Liang Yan zhao Hua Cao Tao chen Xue chen Ai-Ping Feng Song-Mei Geng Heng Gu Shu-Ping Guo Yan-Ling He Ye-Hong Kuang Chun-Ying Li Xiao-Hong Li Zheng-Xiao Li Jun-qin Liang Hong-Ye Liu Ling-Ling Liu yu-Mei Liu Zhi Liu Hai Long Qian-Jin Lu Yan Lu Xiao-Qun Luo Xiao-Yan Lv Lin Ma Zhu Shen Xin Shi Zhong-Xiang Shi Xiang-Yang Su qing Sun Jian-Ping Tang Ao-Xue Wang Hui-Ping Wang Jian-qin Wang Ming-yue Wang Zai-Xing Wang yu-Min Xia Ting Xiao Zhi-Qiang Xie Huan Xing Ying Xiong Zi-gang Xu Bin Yang Zhi-Rong Yao Jian-Bin yu Nan yu Kang Zeng Jian-Zhong Zhang Jun-Ling Zhang Hua zhao Zuo-Tao zhao Wei Zhu Ying-Hua Zhu Ying Zou Atopic Dermatitis Working Group,Immunology Group,chinese Society of Dermatology Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical SciencesNanjingJiangsu 210042China Southwest Hospital of Military Medical University Chongqing 400038China Huashan Hospital Affiliated with Fudan UniversityShanghai 200040China Dermatology Hospital of Southern Medical University GuangzhouGuangdong 510091China Peking University People’s Hospital Beijing 100044China Ruijin Hospital Affiliated with Shanghai Jiaotong UniversityShanghai 310000China chengdu Second People’s Hospital ChengduSichuan 610017China Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology WuhanHubei 430022China The Second Affiliated Hospital of Xi’an Jiaotong University Xi’anShaanxi 710004China First Hospital of Shanxi Medical University TaiyuanShanxi 030012China beijing Chao-Yang Hospital Capital Medical UniversityBeijing 100027China Xiangya Hospital Central South UniversityChangshaHunan 410008China Xijing Hospital Fourth Military Medical UniversityXi’anShaanxi 710032China The First Affiliated Hospital of Zhengzhou University ZhengzhouHenan 450052China People’s Hospital of Xinjiang Uygur Autonomous Region WulumuqiXinjiang 830001China Peking University First Hospital Beijing 100034China Guangzhou Institute of Dermatology GuangzhouGuangdong 510095China The Affiliated Hospital of Guizhou Medical University GuiyangGuizhou 550004China The Second Xiangya Hospital of Central South University ChangshaHunan 410011China The First Affiliated Hospital of Nanjing Medical University NanjingJiangsu 210029China West China Hospital Sichuan UniversityChengduSichuan 610041China beijing Children’s Hospital Capital Medical UniversityBeijing 100045China Sichuan academy of Medical sciences&Sichuan Provincial People’s Hospital ChengduSichuan 610072China The Second Affiliated Hospital of Soochow University SuzhouJiangsu 215004China Shandong Provincial Dermatology Hospital JinanShandong 250022China The Third Affiliated Hospital of Sun Yat-sen U

Atopic dermatitis(AD)is a common disease clinically characterized by chronic recurrent eczematous lesions,dry skin,and *** can negatively impact patients’quality of *** prevalence of AD in China has been increasing during the past few *** on the most recent advances in the treatment of AD,we updated the 2014 version of the Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China regarding the definition,epidemiology,pathogenesis,clinical classification,diagnosis,prevention,and treatment of AD.

关键词： atopic dermatitis diagnosis therapy guideline

三里屯社区9年强化管理对2型糖尿病患者糖尿病视网膜病变和糖尿病肾病的影响研究

在线全文

学校读者我要写书评

暂无评论

中国全科医学 2018年第22期21卷 2696-2701页

作者：赵辰梅崔学利万钢路玉蛰牛玉琴苏成玉曹硕梁冠秀陈宏伟李靖芦霞邓志云于学慧杨文霞李建华樊华杨茂霞付艳魏素萍何志娜吴立平袁申元北京市朝阳区三里屯社区卫生服务中心 100027 首都医科大学附属北京地坛医院病案统计室北京市100015 拜耳医药保健有限公司北京市100020 首都医科大学附属北京同仁医院内分泌科北京市100730

目的研究北京市朝阳区三里屯社区卫生服务中心9年强化管理对2型糖尿病(T2DM)患者糖尿病微血管并发症的影响,探索血糖、血压、血脂水平及联合达标≥3.与微血管并发症预后的关系。方法将三里屯社区2008年入选的224例T2DM患者随机分为强化... 详细信息

目的研究北京市朝阳区三里屯社区卫生服务中心9年强化管理对2型糖尿病(T2DM)患者糖尿病微血管并发症的影响,探索血糖、血压、血脂水平及联合达标≥3.与微血管并发症预后的关系。方法将三里屯社区2008年入选的224例T2DM患者随机分为强化组(113.)和标准组(111例),对其连续管理并随访9年,以收缩压、舒张压、糖化血红蛋白(Hb A1c)、低密度脂蛋白胆固醇(LDL-C)为主要管理指标,比较管理前后两组上述指标的差异;收集终点事件(糖尿病视网膜病变和糖尿病肾病),比较管理后两组终点事件的发生情况;探索分组管理方式和主要指标达标次数是否≥3.与微血管并发症的关系。结果入组时两组患者性别、年龄、病程、吸烟情况、BMI、收缩压、舒张压、空腹血糖(FPG)、餐后2 h血糖(2 h PG)、LDL-C、Hb A1c及尿微量清蛋白排泄率(UAER)比较,差异无统计学意义(P>0.05);管理后强化组FPG、2 h PG、LDL-C、Hb A1c、UAER水平低于标准组,差异有统计学意义(P0.05)。标准组发生或加重的糖尿病视网膜病变6例(5.4%),糖尿病肾病13.(11.7%);强化组发生或加重的糖尿病视网膜病变1例(0.9%),糖尿病肾病5例(4.4%)。两组视网膜病变发生率、糖尿病肾病发生率比较,差异有统计学意义(P3.的患者微血管病变发生率低于Hb A1c和联合达标3.的患者,差异有统计学意义(P3.,更可明显减少上述并发症的发生,提高患者生存质量。

关键词：糖尿病,2型糖尿病视网膜病变糖尿病肾病健康管理